Choosing the Right Sunscreen - Your Questions Answered
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 2 August 2018 In Prevention
Bold claims and conflicting advice about what goes into a good sunscreen make it easy to feel overwhelmed when buying sunscreen. At MRA, we believe that the best sunscreen is one that you will wear. Provided that it meets three simple rules:
Wiser & Stronger – Life after Metastatic Melanoma
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 20 July 2018 In Melanoma Stories, Treatment
For Derrick, it all started with headaches. For the first time in his life, this otherwise perfectly healthy father of two, knew something was wrong.
Uveal ‘Clusters’ in Auburn, AL and Huntersville, NC
When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.
Self-Care is Non-Negotiable: “How Early Detection Saved My Life”
Jackie Labrecque’s life changed with a single phone call when her dermatologist called to tell her that the mole that she tried to ignore for months was melanoma.
We’ve Teamed Up with the American Cancer Society
American Cancer Society and Melanoma Research Alliance have united to fund lifesaving research aimed at reducing side effects and improving outcomes for patients treated with immunotherapy.
Why it Matters: U.S. Preventive Services Task Force Endorses Skin Cancer Prevention Counseling for Children and Young Adults
By Cody Barnett, MPH, MRA Director of Communications & Patient Engagement | 20 May 2018 In News, Prevention
This government-backed panel just put skin cancer prevention counseling on the map.
American Cancer Society and Melanoma Research Alliance Fund Five Innovative Approaches to Reduce Immunotherapy Side Effects
As the world marks Melanoma Awareness Month, the American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) selected the first group of scientists to receive newly established research grants to investigate how to reduce rare, but serious, side effects resulting from cancer treatments with checkpoint inhibitors, a type of immunotherapy.